Results 121 to 130 of about 5,030 (154)

SARS-CoV-2 antibodies in Colombian urban area: follow-up on occupational groups. [PDF]

Rev Cuid
Colmenares-Mejía CC, Quintero-Lesmes DC, Serrano NC, Meneses L, Salazar Acosta I, Idrovo ÁJ, Sanabria-Echeverry DY, Cordero Rebolledo H, Castillo V.   +8 more
europepmc   +1 more source

HCoV-NL63 and HCoV-HKU1 seroprevalence and its relationship with the clinical features of COVID-19 patients from Villavicencio, Colombia [PDF]

Biomedica
Lesmes-Rodríguez LC, Pedraza-Castillo LN, Jaramillo-Hernández DA.   +2 more
europepmc   +1 more source

Estudio de seroprevalencia en personal de salud: Relación de la vacunación con la presencia de infección previa por SARS-COV-2 en el contexto de la campaña nacional de vacunación para coronavirus luego de la primer dosis Gam-COVID-VAc (Sputnik-V)

, 2021
Tortosa F, Parodi V, Carrasco G, Barrientos L, Barriera A, Spano A, Gonzalez M, Roma V, Escudero S, Lossetti L, Sartor M, Laspina S.   +11 more
europepmc   +1 more source

Integrated serosurveillance of multiple communicable diseases in the hinterland of Guyana. [PDF]

Rev Panam Salud Publica
Niles-Robin RA, Sampson A, Valz O, Scott O, Dickson KE, Escalada R, Nicholson D, Woolford J, Paz Ade M, Scholte RC, Luciañez A, Bravo P, Rey-Benito G, Ibarra-Ozcariz S, Morice A, Saboyá-Díaz MI.   +15 more
europepmc   +1 more source

Integrated serological surveillance of communicable diseases in the Paraguayan Chaco, 2019. [PDF]

Rev Panam Salud Publica
Galeano P, Huber C, Ortiz V, Araya S, Pérez VT, Sequera G, Ade MP, Rey-Benito G, Bravo P, Luciañez A, Montoya R, Ibarra-Ozcariz SG, De Egea V, Cabello Á, Morice A, Saboyá-Díaz MI, Goodhew EB, Cooley G, Martin D.   +18 more
europepmc   +1 more source

[Brief history of laboratory-based epidemiological surveillance in the Mexican Institute for Social Security]. [PDF]

Rev Med Inst Mex Seguro Soc
Santacruz-Tinoco CE, Alvarado-Yaah JE, Anguiano-Hernández YM, Martínez-Miguel B, Cabrera-Gaytán DA, Chávez-Navarro L.   +5 more
europepmc   +1 more source

Clinical outcomes of pediatric patients with congenital toxoplasmosis in a fourthlevel center Introduction. Congenital [PDF]

Biomedica
Posada-Bustos S, Mariño AC, Espinosa-García E.   +2 more
europepmc   +1 more source